SELENOK-dependent CD36 palmitoylation regulates microglial functions and A phagocytosis
Redox Biology(2024)
摘要
Amyloid-beta (A beta) is a key factor in the onset and progression of Alzheimer's disease (AD). Selenium (Se) compounds show promise in AD treatment. Here, we revealed that selenoprotein K (SELENOK), a selenoprotein involved in immune regulation and potentially related to AD pathology, plays a critical role in microglial immune response, migration, and phagocytosis. In vivo and in vitro studies corroborated that SELENOK deficiency inhibits microglial A beta phagocytosis, exacerbating cognitive deficits in 5xFAD mice, which are reversed by SELENOK overexpression. Mechanistically, SELENOK is involved in CD36 palmitoylation through DHHC6, regulating CD36 localization to microglial plasma membranes and thus impacting A beta phagocytosis. CD36 palmitoylation was reduced in the brains of patients and mice with AD. Se supplementation promoted SELENOK expression and CD36 palmitoylation, enhancing microglial A beta phagocytosis and mitigating AD progression. We have identified the regulatory mechanisms from Se-dependent selenoproteins to A beta pathology, providing novel insights into potential therapeutic strategies involving Se and selenoproteins.
更多查看译文
关键词
Selenoprotein K,Amyloid-beta,Alzheimer's disease,CD36 palmitoylation,Microglial phagocytosis
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要